The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the antiparasitic drugs industry?
The increasing incidence of vector-borne diseases is expected to propel the growth of the antiparasitic drugs market going forward. Vector-borne diseases refer to infectious diseases transmitted to humans or other animals through the bite of arthropods, primarily insects like mosquitoes, ticks and flies. Some examples of vector-borne diseases include malaria, dengue and yellow fever. Antiparasitic drugs play an essential role in stopping the spread of vector-borne diseases by targeting and eliminating the parasites responsible. A few antiparasitic drugs, including chloroquine, doxycycline and atovaquone-proguanil, are commonly used to cure malaria. For instance, in June 2024, according to the Centers for Disease Control and Prevention, a US-based Government agency, From January to June 2024, over 9.7 million dengue cases were reported across the Americas, more than double the 4.6 million cases reported in 2023. Puerto Rico reported 1,498 dengue cases in the United States, and 745 cases were identified among U.S. travelers returning from affected areas. Therefore, the increasing incidence of vector-borne diseases drives the growth of the antiparasitic drugs market.
Antiparasitic Drugs Market Driver: High Prevalence Of Parasitic Infections Raise Antiparasitic Drug Market
The high prevalence of parasitic infections is expected to drive the growth of the antiparasitic drug market. Parasitic infections are caused by microscopic parasites or larger organisms that live and thrive at the expense of their host organism, often causing harm or disease. Antiparasitic drugs are essential tools in the management and control of parasitic infections, contributing to improved health outcomes and a reduced burden of these diseases on affected individuals and communities. For instance, in May 2024, according to Gov. UK, a UK-based government website in 2022, a total of 31 rickettsial infection cases were reported in EWNI, with 30 in England and 1 in Wales. Of these, 17 (55%) were confirmed cases, while 14 (45%) were classified as probable cases. Therefore, the high prevalence of parasitic infections drives the growth of the antiparasitic drug market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp
What is the estimated market size of the antiparasitic drugs sector by 2029, based on current forecasts?
The antiparasitic drugs market size has grown strongly in recent years. It will grow from $24.06 billion in 2024 to $25.75 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to prevalence of parasitic infections, resistance to existing treatments, global health initiatives, .
The antiparasitic drugs market size is expected to see strong growth in the next few years. It will grow to $33.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to emerging parasitic threats, climate change and vector-borne diseases, increased emphasis on global health security, access to healthcare. Major trends in the forecast period include advances in drug development, targeted therapies, combination therapies, public-private partnerships, telemedicine and remote diagnosis.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp
#Who are the top players in the antiparasitic drugs market?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.
#What are the major trends in the antiparasitic drugs market?
Major companies operating in the antiparasitic drugs market are focusing on developing innovative products such as chewable veterinary products to enhance ease of administration and improve pet compliance. Chewable veterinary products are flavored, easy-to-administer tablets or treats designed to deliver medication to animals. They enhance pet compliance by making treatment more palatable and stress-free. For instance, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a Germany-based pharmaceutical company, launched NexGard Spectra to provide comprehensive parasite control. NexGard SPECTRA is a soft, flavorful chew that provides comprehensive internal and external parasite control for dogs, effectively targeting fleas, ticks, heartworms, and various intestinal worms in a single monthly dose. It demonstrates rapid action by killing fleas within four hours of administration and achieving over 99% effectiveness against multiple parasites shortly thereafter .
Which geography holds the highest antiparasitic drugs market share?
North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
How do different segments contribute to the overall expansion of the antiparasitic drugs market?
The antiparasitic drugs market covered in this report is segmented –
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12927
What defines the structure and scope of the antiparasitic drugs market?
Antiparasitic drugs are medications used to treat infections caused by various parasites that can infect humans, animals, or plants. Parasites are organisms that live on or within a host organism and derive their nutrients from it, often causing harm to the host in the process. Antiparasitic drugs target these parasites to either kill them or inhibit their growth.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
